Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma
Condition(s):Recurrent Follicular LymphomaLast Updated:January 30, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Recurrent Follicular LymphomaLast Updated:January 30, 2018Completed
Condition(s):LymphomaLast Updated:April 30, 2015Completed
Condition(s):Recurrent Follicular LymphomaLast Updated:December 14, 2015Recruiting
Condition(s):Recurrent Follicular Lymphoma; Refractory Follicular LymphomaLast Updated:May 31, 2023Withdrawn
Condition(s):Recurrent Follicular Lymphoma; Refractory Follicular LymphomaLast Updated:January 22, 2024Recruiting
Condition(s):Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular LymphomaLast Updated:February 2, 2024Active, not recruiting
Condition(s):Grade 3b Follicular Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Non-Hodgkin’s LymphomaLast Updated:June 29, 2023Terminated
Condition(s):Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Refractory Follicular LymphomaLast Updated:March 27, 2024Recruiting
Condition(s):Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Stage III/IV Adult Diffuse Large Cell Lymphoma; Stage III/IV Follicular Lymphoma; Stage III/IV Mantle Cell LymphomaLast Updated:March 10, 2017Unknown status
Condition(s):Indolent B-Cell Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Mucosa-Associated Lymphoid Tissue Lymphoma; Recurrent Follicular Lymphoma; Recurrent Hairy Cell Leukemia; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Mucosa-Associated Lymphoid Tissue Lymphoma; Refractory Follicular Lymphoma; Refractory Hairy Cell Leukemia; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Small Lymphocytic LymphomaLast Updated:September 15, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.